Shiba Y, Anzai S, Ueda T, Sasa N, Yamagami T, Omori Y
Fukushima J Med Sci. 2024; 70(4):183-192.
PMID: 39370275
PMC: 11625852.
DOI: 10.5387/fms.23-00013.
Chen L, Zhen W, Peng D
Front Psychiatry. 2023; 14:1227261.
PMID: 37680449
PMC: 10482043.
DOI: 10.3389/fpsyt.2023.1227261.
Fujiwara A, Fukunaga A, Murakami K, Inoue Y, Nakagawa T, Yamamoto S
Nutrients. 2023; 15(13).
PMID: 37447360
PMC: 10346684.
DOI: 10.3390/nu15133034.
Kouzuki M, Tanaka N, Miyamoto M, Urakami K
BMC Geriatr. 2023; 23(1):397.
PMID: 37380967
PMC: 10308771.
DOI: 10.1186/s12877-023-04119-2.
Fujiwara A, Fukunaga A, Murakami K, Inoue Y, Nakagawa T, Yamamoto S
Nutrients. 2023; 15(11).
PMID: 37299449
PMC: 10255220.
DOI: 10.3390/nu15112485.
Validation of a novel computerized cognitive function test for the rapid detection of mild cognitive impairment.
Kouzuki M, Miyamoto M, Tanaka N, Urakami K
BMC Neurol. 2022; 22(1):457.
PMID: 36476188
PMC: 9727980.
DOI: 10.1186/s12883-022-02997-4.
Dementia Prevention and Aromatherapy in Japan.
Urakami K
Yonago Acta Med. 2022; 65(3):184-190.
PMID: 36061582
PMC: 9419217.
DOI: 10.33160/yam.2022.08.001.
A voice recognition-based digital cognitive screener for dementia detection in the community: Development and validation study.
Zhao X, Hu R, Wen H, Xu G, Pang T, He X
Front Psychiatry. 2022; 13:899729.
PMID: 35935417
PMC: 9354045.
DOI: 10.3389/fpsyt.2022.899729.
Digital Cognitive Biomarker for Mild Cognitive Impairments and Dementia: A Systematic Review.
Ding Z, Lee T, Chan A
J Clin Med. 2022; 11(14).
PMID: 35887956
PMC: 9320101.
DOI: 10.3390/jcm11144191.
Association between the inability to identify particular odors and physical performance, cognitive function, and/or brain atrophy in community-dwelling older adults from the Fukuoka Island City study.
Kose Y, Hatamoto Y, Takae R, Tomiga Y, Yasukata J, Komiyama T
BMC Geriatr. 2021; 21(1):421.
PMID: 34247577
PMC: 8274001.
DOI: 10.1186/s12877-021-02363-y.
Validation of SATURN, a free, electronic, self-administered cognitive screening test.
Bissig D, Kaye J, Erten-Lyons D
Alzheimers Dement (N Y). 2021; 6(1):e12116.
PMID: 33392382
PMC: 7771179.
DOI: 10.1002/trc2.12116.
A program of exercise, brain training, and lecture to prevent cognitive decline.
Kouzuki M, Kato T, Wada-Isoe K, Takeda S, Tamura A, Takanashi Y
Ann Clin Transl Neurol. 2020; 7(3):318-328.
PMID: 32068975
PMC: 7085994.
DOI: 10.1002/acn3.50993.
Development and validity of the Computer-Based Cognitive Assessment Tool for intervention in community-dwelling older individuals.
Takahashi J, Kawai H, Suzuki H, Fujiwara Y, Watanabe Y, Hirano H
Geriatr Gerontol Int. 2020; 20(3):171-175.
PMID: 31916344
PMC: 7065126.
DOI: 10.1111/ggi.13836.
Characteristics of Mild Cognitive Impairment in Northern Japanese Community-Dwellers from the ORANGE Registry.
Kume Y, Takahashi T, Itakura Y, Lee S, Makizako H, Ono T
J Clin Med. 2019; 8(11).
PMID: 31717664
PMC: 6912714.
DOI: 10.3390/jcm8111937.
Physical Activity and/or High Protein Intake Maintains Fat-Free Mass in Older People with Mild Disability; the Fukuoka Island City Study: A Cross-Sectional Study.
Takae R, Hatamoto Y, Yasukata J, Kose Y, Komiyama T, Ikenaga M
Nutrients. 2019; 11(11).
PMID: 31671741
PMC: 6893506.
DOI: 10.3390/nu11112595.
Brief cognitive screening instruments for early detection of Alzheimer's disease: a systematic review.
De Roeck E, De Deyn P, Dierckx E, Engelborghs S
Alzheimers Res Ther. 2019; 11(1):21.
PMID: 30819244
PMC: 6396539.
DOI: 10.1186/s13195-019-0474-3.
Muscle mass decline, arterial stiffness, white matter hyperintensity, and cognitive impairment: Japan Shimanami Health Promoting Program study.
Kohara K, Okada Y, Ochi M, Ohara M, Nagai T, Tabara Y
J Cachexia Sarcopenia Muscle. 2017; 8(4):557-566.
PMID: 28371474
PMC: 5566649.
DOI: 10.1002/jcsm.12195.
Changes in Cognitive Functions in the Elderly Living in Temporary Housing after the Great East Japan Earthquake.
Ishiki A, Okinaga S, Tomita N, Kawahara R, Tsuji I, Nagatomi R
PLoS One. 2016; 11(1):e0147025.
PMID: 26760971
PMC: 4720119.
DOI: 10.1371/journal.pone.0147025.
Computerized cognitive testing for older adults: a review.
Zygouris S, Tsolaki M
Am J Alzheimers Dis Other Demen. 2014; 30(1):13-28.
PMID: 24526761
PMC: 10852880.
DOI: 10.1177/1533317514522852.
A warning index used in prescreening for Alzheimer's disease, based on self-reported cognitive deficits and vascular risk factors for dementia in elderly patients with type 2 diabetes.
Matsuzawa T, Takata T, Yokono K, Ueda H, Moriwaki K, Kamae I
Int J Alzheimers Dis. 2012; 2012:124215.
PMID: 23119223
PMC: 3478737.
DOI: 10.1155/2012/124215.